BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.52B |
| 2 |
Visa
V
|
+$442M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$391M |
| 4 |
DuPont de Nemours
DD
|
+$296M |
| 5 |
NVIDIA
NVDA
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$643M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$407M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$245M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$243M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.29% |
| 2 | Consumer Discretionary | 8.84% |
| 3 | Healthcare | 6.65% |
| 4 | Financials | 5.52% |
| 5 | Industrials | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
AMES National
ATLO
$281M
| $55K | ﹤0.01% |
3,053
+2,991
| +4,824% | +$56.2K |
|
3327
Ranger Energy Services
RNGR
$405M
| $55K | ﹤0.01% |
+5,368
| New | +$60.2K |
|
3328
Acacia Research
ACTG
$449M
| $54.9K | ﹤0.01% |
+13,194
| New | +$53.2K |
|
3329
Tilly's
TLYS
$122M
| $54.9K | ﹤0.01% |
7,829
-7,826
| -50% | -$57.4K |
|
|
MBCN
3330
DELISTED
Middlefield Banc Corp
MBCN
| $54.7K | ﹤0.01% |
+2,042
| New | +$53.4K |
|
3331
FS Bancorp
FSBW
$326M
| $54K | ﹤0.01% |
1,797
+1,719
| +2,204% | +$50.5K |
|
3332
Silvercrest Asset Management
SAMG
$79.5M
| $53.8K | ﹤0.01% |
2,659
-8,996
| -77% | -$172K |
|
3333
Rocky Brands
RCKY
$353M
| $53.7K | ﹤0.01% |
2,556
-2,218
| -46% | -$48.7K |
|
3334
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $53.6K | ﹤0.01% |
1,270
+867
| +215% | +$37.5K |
|
3335
Bridgewater Bancshares
BWB
$620M
| $53.2K | ﹤0.01% |
5,404
-4,751
| -47% | -$45.7K |
|
3336
Mind CTI
MNDO
$20.6M
| $53.1K | ﹤0.01% |
27,219
+18,619
| +217% | +$36.3K |
|
3337
Greene County Bancorp
GCBC
$595M
| $53K | ﹤0.01% |
1,780
-373
| -17% | -$8.98K |
|
3338
UroGen Pharma
URGN
$2.34B
| $52.8K | ﹤0.01% |
5,102
+4,925
| +2,782% | +$54.3K |
|
3339
Clean Energy Fuels
CLNE
$395M
| $52.4K | ﹤0.01% |
10,574
-67,772
| -87% | -$297K |
|
3340
Southern First Bancshares
SFST
$612M
| $52.2K | ﹤0.01% |
2,109
-1,986
| -48% | -$51.8K |
|
3341
Mercer International
MERC
$33.8M
| $51.6K | ﹤0.01% |
6,396
+1,440
| +29% | +$13.1K |
|
3342
KB Financial Group
KB
$41.7B
| $51.6K | ﹤0.01% |
1,417
+224
| +19% | +$8.26K |
|
3343
Parke Bancorp
PKBK
$413M
| $51.6K | ﹤0.01% |
3,035
-2,331
| -43% | -$39.1K |
|
|
STRS
3344
DELISTED
STRATUS PPTYS INC
STRS
| $51.6K | ﹤0.01% |
1,964
-2,074
| -51% | -$47K |
|
3345
NACCO Industries
NC
$316M
| $51.4K | ﹤0.01% |
1,482
-1,390
| -48% | -$47.5K |
|
3346
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
| $51.3K | ﹤0.01% |
704
-45
| -6% | -$3.28K |
|
|
TIO
3347
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $51.3K | ﹤0.01% |
+42,381
| New | +$95.6K |
|
3348
Restaurant Brands International
QSR
$26.7B
| $51.2K | ﹤0.01% |
660
+174
| +36% | +$12.6K |
|
3349
Nomad Foods
NOMD
$1.68B
| $51.1K | ﹤0.01% |
2,918
-319,325
| -99% | -$5.81M |
|
3350
Ovid Therapeutics
OVID
$523M
| $50.9K | ﹤0.01% |
15,505
+15,504
| +1,550,400% | +$52.6K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2023 Portfolio in Review
As of Q2 2023, BNP Paribas Financial Markets held 4,079 positions worth $80B, up 12% from $71.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets's Q2 2023 filing shows 263 new, 1,328 increased, 1,932 reduced and 164 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M. The largest sale was Invesco QQQ Trust, an estimated $643M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- BNP Paribas Financial Markets's largest Q2 2023 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M.
- BNP Paribas Financial Markets added most to Alibaba in Q2 2023, an estimated $1.52B increase.
- BNP Paribas Financial Markets's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $643M.
- BNP Paribas Financial Markets fully exited iShares Russell Mid-Cap Growth ETF in Q2 2023, selling an estimated $35.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $80B portfolio in Q2 2023.
- BNP Paribas Financial Markets opened 263 new positions and closed 164 in Q2 2023.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $80B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.